摘要 |
The invention relates to 4-substituted quinoline compounds of general formula: which are active as antimicrobials, in which: X<SUB>1</SUB>, X<SUB>2</SUB>, X<SUB>3</SUB>, X<SUB>4 </SUB>and X<SUB>5 </SUB>is C-R'<SUB>1</SUB>, to C-R'<SUB>5 </SUB>respectively, or alternatively at most one represents N, Y represents CHR, CO, CROH, CRNH<SUB>2</SUB>, CRF or CF<SUB>2</SUB>, R being a hydrogen or alkyl, m is 1, 2 or 3 and n is 0, 1 or 2, Z is CH<SUB>2 </SUB>or Z is O, S, SO, SO<SUB>2 </SUB>and, in this case, n is equal to 2, R<SUB>2 </SUB>is -CO<SUB>2</SUB>R, -CH<SUB>2</SUB>CO<SUB>2</SUB>R, -CH<SUB>2</SUB>-CH<SUB>2</SUB>CO<SUB>2</SUB>R, -CH<SUB>2</SUB>OH or -CH<SUB>2</SUB>-CH<SUB>2</SUB>OH, wherein R is as defined above, R<SUB>3 </SUB>represents phenyl, heteroaryl or alk-R<SUP>o</SUP><SUB>3</SUB>, where alk is alkyl and R<SUP>o</SUP><SUB>3 </SUB>represents various groups, where appropriate containing oxygen, sulfur or amine, in their enantiomeric or diastereoisomeric forms or their mixtures, and/or where appropriate in the syn or anti form or their mixtures, and their salts.
|